Klinische Studie

VR Therapies for IBD

NCT: NCT07590518 · NOT_YET_RECRUITING

NCT-IDNCT07590518

Medizinische Daten: StatusNOT_YET_RECRUITING

SponsorBrennan Spiegel (OTHER)

First posted2026-05-15

Last updated2026-05-15

Kurzzusammenfassung

Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.